These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 211804

  • 1. Small cell carcinoma of the lung: serum calcitonin and serum histaminase (diamine oxidase) at basal levels and stimulated by pentagastrin.
    Hansen M, Hansen HH, Tryding N.
    Acta Med Scand; 1978; 204(4):257-61. PubMed ID: 211804
    [Abstract] [Full Text] [Related]

  • 2. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
    Samaan NA, Castillo S, Schultz PN, Khalil KG, Johnston DA.
    J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
    [Abstract] [Full Text] [Related]

  • 3. Ectopic secretion of calcitonin.
    Mulder H, Hackeng WH.
    Acta Med Scand; 1978 Aug; 204(4):253-6. PubMed ID: 696425
    [Abstract] [Full Text] [Related]

  • 4. Elevated histaminase (diamine oxidase) activity in small-cell carcinoma of the lung.
    Baylin SB, Abeloff MD, Wieman KC, Tomford JW, Ettinger DS.
    N Engl J Med; 1975 Dec 18; 293(25):1286-90. PubMed ID: 171575
    [Abstract] [Full Text] [Related]

  • 5. ACTH, ADH, and calcitonin concentrations as markers of response and relapse in small-cell carcinoma of the lung.
    Hansen M, Hammer M, Hummer L.
    Cancer; 1980 Nov 01; 46(9):2062-7. PubMed ID: 6253049
    [Abstract] [Full Text] [Related]

  • 6. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
    Telenius-Berg M, Almqvist S, Berg B, Hedner P, Ingemansson S, Tibblin S, Wasthed B.
    Eur J Clin Invest; 1977 Feb 01; 7(1):7-16. PubMed ID: 402280
    [Abstract] [Full Text] [Related]

  • 7. Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation.
    Machens A, Haedecke J, Holzhausen HJ, Thomusch O, Schneyer U, Dralle H.
    Langenbecks Arch Surg; 2000 Oct 01; 385(6):398-401. PubMed ID: 11127524
    [Abstract] [Full Text] [Related]

  • 8. Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types.
    Winkelmann W, Deuss U, Allolio B, Hummerich W, Kaulen D, Brosch H, Guyot A, Arnold C.
    Klin Wochenschr; 1984 Nov 02; 62(21):1018-24. PubMed ID: 6096627
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
    Gordin A, Lamberg BA, Pelkonen R, Almqvist S.
    Clin Endocrinol (Oxf); 1978 Apr 02; 8(4):289-93. PubMed ID: 647984
    [Abstract] [Full Text] [Related]

  • 10. No effect of cimetidine on calcitonin secretion from medullary thyroid carcinoma.
    Emmertsen K, Nielsen HE, Mosekilde L, Hansen HH.
    Acta Med Scand; 1980 Apr 02; 207(5):367-9. PubMed ID: 7386230
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of occult familial medullary carcinoma of the thyroid using pentagastrin.
    Starling JR, Harris C, Granner DK.
    Arch Surg; 1978 Mar 02; 113(3):241-3. PubMed ID: 637688
    [Abstract] [Full Text] [Related]

  • 12. Letter: Plasma-calcitonin and non-thyroid tumours.
    Greenfield B.
    Lancet; 1974 Jul 20; 2(7873):164. PubMed ID: 4135563
    [No Abstract] [Full Text] [Related]

  • 13. Serum histaminase and calcitonin levels in medullary carcinoma of the thyroid.
    Baylin SB, Beaven MA, Keiser HR, Tashjian AH, Melvin KE.
    Lancet; 1972 Feb 26; 1(7748):455-8. PubMed ID: 4109815
    [No Abstract] [Full Text] [Related]

  • 14. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
    Borchhardt KA, Heinzl H, Gessl A, Hörl WH, Kaserer K, Sunder-Plassmann G.
    Kidney Int; 2006 Dec 26; 70(11):2014-20. PubMed ID: 17051143
    [Abstract] [Full Text] [Related]

  • 15. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
    Emmertsen KK, Nielsen HE, Mosekilde L, Hansen HH.
    Acta Radiol Oncol; 1980 Dec 26; 19(2):85-9. PubMed ID: 6254339
    [Abstract] [Full Text] [Related]

  • 16. Histamine and calcitonin release from medullary thyroid carcinoma.
    Farndon JR, Lewis KR, Dale JK, Hinshaw WM, Dilley WG, Wells SA.
    Cancer; 1983 Apr 01; 51(7):1221-5. PubMed ID: 6130834
    [Abstract] [Full Text] [Related]

  • 17. Thyroid cancer: tumour markers.
    Stevenson JC, Hillyard CJ.
    Recent Results Cancer Res; 1980 Apr 01; 73():60-7. PubMed ID: 6785846
    [No Abstract] [Full Text] [Related]

  • 18. Endocrine-related biochemistry in the spectrum of human lung carcinoma.
    Berger CL, Goodwin G, Mendelsohn G, Eggleston JC, Abeloff MD, Aisner S, Baylin SB.
    J Clin Endocrinol Metab; 1981 Aug 01; 53(2):422-9. PubMed ID: 6114110
    [Abstract] [Full Text] [Related]

  • 19. Is thyrotropin-releasing hormone as reliable a calcitonin stimulant as pentagastrin in medullary thyroid carcinoma?
    Ahuja S.
    Acta Endocrinol (Copenh); 1990 May 01; 122(5):640-2. PubMed ID: 2112816
    [Abstract] [Full Text] [Related]

  • 20. Ectopic production of calcitonin.
    Silva OL, Becker KL, Primack A, Doppman J, Snider RH.
    Lancet; 1973 Aug 11; 2(7824):317. PubMed ID: 4124787
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.